Never miss a signal from your portfolio. Know when to reach out.

Raised $42 million in a Series B led by Scale Venture Partners to expand developer compute infrastructure that speeds up software engineering. The round comes seven months after its Series A and brings total funding to $65 million.

Catch-up from Oct 5, 2026

Expanded its partnership with GSK, according to biotech observer BioTender, who reported that GSK found binders for every target tested when evaluating Chai's AI-designed molecules in its wet labs. That describes target coverage, not a 100% success rate for individual molecules; the available evidence is limited to the observer's post.

How to read confidence

High — direct or well-corroborated

Medium — credible attributed reporting

Low — limited, with qualifications

Confidence covers what was reported, not whether the underlying claim is true.

Catch-up identifies important coverage missed in earlier issues.